SCHEMBL7842290

SCHEMBL7842290

CCCCc1nc(Cl)c(C=O)n1Cc1ccc(C(c2nnn(C(c3ccccc3)(c3ccccc3)c3ccccc3)n2)C2CCCC2)cc1

nearest known ligand 0.47

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
AGTR1 P30556 6/20 0.47
AGTR2 P50052 4/20 0.47
GP6 Q9HCN6 1/20 0.45
MME P08473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9154122 0.87 AGTR1 (0.46) AGTR1AGTR2GP6MME
SCHEMBL8976726 0.82 AGTR1 (0.48) AGTR1AGTR2GP6
SCHEMBL8976721 0.82 AGTR1 (0.48) AGTR1AGTR2GP6
SCHEMBL8976717 0.82 AGTR1 (0.48) AGTR1AGTR2GP6
SCHEMBL9136944 0.80 GP6 (0.58) AGTR1AGTR2GP6
SCHEMBL7839432 0.78 GP6 (0.51) AGTR1AGTR2GP6
SCHEMBL3872489 0.78 GP6 (0.66) AGTR1AGTR2GP6
SCHEMBL7839994 0.76 AGTR1 (0.56) AGTR1AGTR2GP6
SCHEMBL9092277 0.75 AGTR1 (0.56) AGTR1AGTR2GP6
SCHEMBL9284564 0.74 AGTR1 (0.46) AGTR1AGTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0513533-B1 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application BAYER AG (DE) 2001-11-21 EP disclosed
EP-1127880-A2 Phenylacetic acid derivatives substituted by a heterocycle and their use as A-II antagonists and as inhibitors of smooth muscle cell proliferation BAYER AG (DE) 2001-08-29 EP disclosed
US-5776964-A HYPOTENSIVE AGENTS; ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS BAYER AKTIENGESELLSCHAFT (DE) 1998-07-07 US disclosed
US-5521206-A HYPOTENSIVE AGENTS, TREATMENT OF ATHEROSCLEROSIS BAYER AKTIENGESELLSCHAFT (DE) 1996-05-28 US disclosed
EP-0513533-A2 Heterocyclic substituted phenylacetic-acid derivatives, process for their preparation and their pharmaceutical application BAYER AG (DE) 1992-11-19 EP disclosed